506(b) Private Placement · Accredited Investors Only

Regenerative Medicine.
Institutional Scale.

A physician-led longevity and performance platform engineered for national franchise expansion — $3.25M 506(b) SAFE at $10M pre-money. Targeting $52M revenue and a $100–180M exit by 2030.

🏥
Visit RegenHealth Physicians
Explore our clinical practice, treatment protocols, and physician team at our flagship NYC location.
rhpny.com ↗
📋
Execute NDA & Request Access
Accredited investors — complete your profile, execute our NDA, and receive secure data room credentials.
Begin registration →
🔐
Enter Investor Data Room
Access confidential offering documents, financial projections, pitch deck, and due diligence materials.
Enter with credentials →
$3.25M
Round 1 Raise
$10M
Pre-Money Valuation
20%
SAFE Discount
$52M
Year 5 Revenue Target
$180M
Exit Target (2030)
01

Built for the $180 Billion Longevity Market

Four structural advantages that compound as the network scales — creating a defensible, physician-led platform competitors cannot easily replicate.

$52M
Year 5 Revenue
From 7 operating locations at close to 55 by 2030, generating $52M in consolidated revenue across corporate and franchise units.
40%
EBITDA Margin at Scale
Platform economics — franchise royalties, membership subscriptions, and Fulcrum technology revenue — drive industry-leading margin expansion.
$180M
Exit Valuation Target
$100–180M exit range at 10–15× EBITDA multiple within a 5-year horizon. Comparable healthcare networks have transacted at premium multiples.
506(b)
Instrument & Structure
SAFE note at $10M pre-money with 20% discount. MSO-compliant, physician-owned structure across all regulated markets.
02
Regen Wellness

Three Brands.
One Scalable Platform.

Wellness Franchise Group operates a vertically integrated, three-tier brand architecture — each tier engineered for a distinct market segment, capital profile, and operator type.

Tier 1 · Operating Now
RegenHealth Physicians
~1,000 sq ft · $300K avg annual revenue · Satellite clinic model · NYC & Salt Lake City active · 5 additional markets at raise close
Tier 2 · Launching Q3 2026
Regen Wellness Center
3,500–4,000 sq ft · $900K avg annual revenue · Full-service wellness and IV therapy center · Franchise-ready FDD in development
Tier 3 · Under Evaluation
Aethera Wellness Institute
80,516–320,000 sq ft (3 development options) · Wynwood Miami Opportunity Zone · $8M avg annual revenue · Hotel/resort longevity concept
03

7 Markets at Close.
55 Locations by 2030.

Capital deployment at close activates satellite clinics across seven strategic markets simultaneously, with Fulcrum Performance Labs co-location model accelerating unit economics.

New York City
● Flagship — Operating
Salt Lake City
● Soft Open — April 2026
Nashville, TN
Opening at raise close
Austin, TX
Opening at raise close
Miami, FL
Opening at raise close
Bay Area, CA
Opening at raise close
Boston, MA
Opening at raise close
7
Year 1 Locations
55
Year 5 Locations
$52M
Year 5 Revenue
$21M
Year 5 EBITDA
Future Vision · Under Evaluation

Aethera Wellness Institute

A luxury longevity resort and hotel concept on a 0.48-acre Wynwood Miami Qualified Opportunity Zone parcel — three development options from 80,516 to 320,000 sq ft. Medical tourism, elite recovery, and regenerative science at institutional scale.

Explore Aethera Club →
04

Request a Management Briefing

30-minute private call with James Zimbler (CEO) and Dr. Ajit Dhaliwal (CMO). Available Monday through Friday during the hours below.

info@regenhealthmd.com
🏥
Dr. Ajit Dhaliwal, MD — Chief Medical Officer · rhpny.com
📋
Jaye Patel — Director of Business Development
📋
Execute NDA & Request Access
Submit your investor profile and execute our non-disclosure agreement to receive secure data room credentials.
🔐
Access Investor Data Room
Existing credentialed investors — enter your secure access code to view all offering materials.
Available Hours — Eastern Time
Monday – Friday10:00 AM – 3:00 PM
Monday – Friday6:00 PM – 9:00 PM